Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2003
05/27/2003US6569471 Administering water and/or fat-soluble cytosolic extract of pollen with Royal Jelly and Vitamin E to treat hormonal variations in fertile, peri- and post- menopausal women
05/27/2003US6569460 Film-coated tablet for improved upper gastrointestinal tract safety
05/27/2003US6569446 Solubilization of flavonols
05/27/2003US6569443 Topical treatment or prevention of ocular infections
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003US6569410 Sun protection compositions containing UV protection factors and esters of hydroxycarboxylic acids and alk(en)yl oligoglycosides
05/27/2003CA2310960C Phosphate-binding polymers for oral administration
05/27/2003CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
05/27/2003CA2231558C .gamma.-rar antagonist ligand or .alpha.-rar agonist ligand as an apoptosis inhibitor
05/27/2003CA2140866C Use of inhibitors of fatty acid synthesis for treating cancer
05/22/2003WO2003042399A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003WO2003042390A1 Mammalian protein phosphatases
05/22/2003WO2003042381A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042344A2 Apo2 ligand/trail formulations
05/22/2003WO2003042216A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003WO2003042210A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/22/2003WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003WO2003042174A1 Cannabinoid receptor ligands
05/22/2003WO2003042173A1 Nk1 antagonists
05/22/2003WO2003042172A2 C-5 modified indazolylpyrrolotriazines
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003041754A1 Medical devices having antimicrobial coatings thereon
05/22/2003WO2003041743A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
05/22/2003WO2003041741A1 Method of preventing or treating benign gynaecological disorders
05/22/2003WO2003041739A1 Anticaner agents
05/22/2003WO2003041725A2 Regulation of cgmp-specific phosphodiesterase 9a
05/22/2003WO2003041713A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
05/22/2003WO2003041701A2 Preparation for improving the action of receptors
05/22/2003WO2003041688A1 Methods for treatment of inflammatory diseases
05/22/2003WO2003041685A1 Injectable depot composition
05/22/2003WO2003041684A2 Injectable depot compositions and uses thereof
05/22/2003WO2003041669A1 A composition for promoting hair growth
05/22/2003WO2003041654A2 Anti-estrogen and immune modulator combinations for treating breast cancer
05/22/2003WO2003041650A2 Modulation of lir function to treat rheumatoid arthritis
05/22/2003WO2003041643A2 Hsp90-inhibiting zearalanol compounds and methods of producing and using same
05/22/2003WO2003041563A2 Neurotransmitter balance chemotherapy
05/22/2003WO2003028646A3 Methods of treating drug-resistant bacterial infections
05/22/2003WO2003027255A3 Anti-fusion assay
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003011277A3 Methods to mobilize progenitor/stem cells
05/22/2003WO2002100353A3 Cd10-activated prodrug compounds
05/22/2003WO2002095393A3 Drug evolution: drug design at hot spots
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2002083120A3 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
05/22/2003WO2002078766A3 Combination therapy
05/22/2003WO2002076390A3 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
05/22/2003WO2002060419A3 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
05/22/2003WO2002056912A3 Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002053141A3 Inhibition of angiogenesis by nucleic acids
05/22/2003WO2002051430A3 Methods of modulating toll-related receptor (trr) signaling
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002045749A8 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
05/22/2003WO2002044168A3 Indole-type inhibitors of p38 kinase
05/22/2003WO2002043719A3 Composition and method for treating snoring
05/22/2003WO2002041891A3 Hiv treatment with benzimidazoles
05/22/2003WO2002041879A3 Antidiabetic compositions containing a biguanide and a sulfonamide
05/22/2003WO2002039958A9 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
05/22/2003WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
05/22/2003WO2001074298A3 Methods and compositions for regulating memory consolidation
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003US20030097671 Inhibition of betaarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
05/22/2003US20030097220 System and methods for optimized drug delivery and progression of diseased and normal cells
05/22/2003US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/22/2003US20030096874 For prophylaxis and therapy of respiratory diseases asthma, chronic obstructive pulmonary disease (COPD), respiratory tract infection or upper respiratory tract disease
05/22/2003US20030096869 Locating an artery which carries major blood supply to the tumor; intra-arterially injecting into the located artery a predetermined quantity of a polyunsaturated fatty acid solution and anti-antiogenic substances
05/22/2003US20030096867 To increase the HDL (High density lipoproteins) cholesterol level in blood for prophylaxis of arteriosclerosis
05/22/2003US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite
05/22/2003US20030096852 Inhibiting binding interaction between hGH (human growth hormone) or a mutant thereof and an hGH binding protein or receptor in mammal administering benzimidazole compound
05/22/2003US20030096850 Treating infections by administration of oxazolidinones
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096834 Pharmaceutical compositions
05/22/2003US20030096832 Method of treating pain using nalbuphine and opioid antagonists
05/22/2003US20030096829 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
05/22/2003US20030096825 Antiviral activity; treatment of HIV and AIDS
05/22/2003US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
05/22/2003US20030096807 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
05/22/2003US20030096799 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity
05/22/2003US20030096798 Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096794 Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
05/22/2003US20030096792 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors
05/22/2003US20030096789 For example, camptothecin derivatives such as irinotecan with capecitabine, gemcitabine or multi-targeted antifolate (MTA), also known as pemetrexed
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096782 Expression profiling in the intact human heart
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096777 Antisense oligonucleotides which inhibit expression of a gene in operable association with protein effectors of that gene's product; DNA methyltransferase is inhibited at the genetic level as well as at the protein level; antitumor
05/22/2003US20030096774 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
05/22/2003US20030096762 Compositions and methods for cystic fibrosis therapy
05/22/2003US20030096761 Angiotensin converting enzyme (ACE) and/or neutral endopeptidase (NEP); organic acids and salts thereof, sodium lauryl sulfate and palmitoyl carnitine enhancers used in treating cardiovascular disorders
05/22/2003US20030096755 Suppression of inhibitors
05/22/2003US20030096705 Antagonists of MCP-1 function and methods of use thereof
05/22/2003US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease
05/22/2003US20030096327 Detection of tumor disorder in humans; obtain tissue sample, screen for presence of tumor marker, presence of marker indicates tumor disorder
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096311 Detection of allergic response in humans; obtain interferon sample, incubate wot test agent, detect conjugation between interferon and agent, conjugation indicates induction of allergies
1 ... 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 ... 1151